India
· Delayed Price · Currency is INR Emcure Pharmaceuticals Company Description
Emcure Pharmaceuticals Limited engages in the developing, manufacturing, and marketing pharmaceutical products worldwide.
It offers products in various therapeutic areas, such as gynecology, cardiovascular, anti-infectives, HIV antivirals, respiratory, gastrointestinal, pain and analgesics, blood related, oncology/anti-neoplastics, anti-diabetic, hormones, neurology/central nervous system, dermatology, and other areas, as well as vitamins, minerals, and nutrients.
The company also develops products across various platforms, including chiral molecules, complex APIs, orals, iron products, photo-chemistry products, liposomal and lyophilized injectables, high potency drugs, biotherapeutics, and novel drug delivery systems.
It provides its products under Orofer, Bevon, Maxtra, Zostum, Metpure, and Eslo brand names. Emcure Pharmaceuticals Limited was incorporated in 1981 and is based in Pune, India.
| Country | India |
| Founded | 1981 |
| Industry | Pharmaceutical Preparations |
| Employees | 10,852 |
| CEO | Satish Mehta |
Contact Details
Address: Plot No. P-1 and P-2 Pune, Maharashtra 411057 India | |
| Phone | 91 20 3507 0033 |
| Website | emcure.com |
Stock Details
| Ticker Symbol | 544210 |
| Exchange | Bombay Stock Exchange |
| Fiscal Year | April - March |
| Reporting Currency | INR |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Satish Mehta | Chief Executive Officer |
| Tajuddin Shaikh | Chief Financial Officer |
| Samit Mehta | Chief Operating Officer |